VKTX (STOCKS)
Viking Therapeutics, Inc
$32.280000
+3.530000 (+12.28%)
Prev close: $28.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Brian Lian
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,265.79M
- Employees
- 51
- P/E (TTM)
- -13.48
- P/B (TTM)
- 4.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $274.84M |
| Research and Development | $222.48M |
| Other Operating Expenses | $52.36M |
| Operating Income/Loss | -$274.84M |
| Income/Loss From Continuing Operations After Tax | -$237.39M |
| Income/Loss From Continuing Operations Before Tax | -$237.39M |
| Net Income/Loss | -$237.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$237.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$237.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.12 |
| Diluted Earnings Per Share | -$2.12 |
| Basic Average Shares | 112,992,000 |
| Diluted Average Shares | 112,992,000 |
| Assets | $739.42M |
| Current Assets | $738.70M |
| Noncurrent Assets | $712.00K |
| Liabilities | $26.39M |
| Current Liabilities | $26.07M |
| Accounts Payable | $4.41M |
| Other Current Liabilities | $21.65M |
| Noncurrent Liabilities | $318.00K |
| Equity | $713.03M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $713.03M |
| Liabilities And Equity | $739.42M |
| Net Cash Flow From Operating Activities | -$224.58M |
| Net Cash Flow From Operating Activities, Continuing | -$224.58M |
| Net Cash Flow From Investing Activities | $272.36M |
| Net Cash Flow From Investing Activities, Continuing | $272.36M |
| Net Cash Flow From Financing Activities | $2.34M |
| Net Cash Flow From Financing Activities, Continuing | $2.34M |
| Net Cash Flow | $50.12M |
| Net Cash Flow, Continuing | $50.12M |
| Comprehensive Income/Loss | -$238.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$238.65M |
| Other Comprehensive Income/Loss | -$1.26M |